Inactive Instrument

Other languages AVEO Pharmaceuticals, Inc.

Equities

AVEO

US0535883070

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

AVEO Pharmaceuticals, Inc. Announces Executive Changes	Mar. 25
Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist	Feb. 06
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)	Jan. 16
AVEO Oncology Announces Completion of Enrollment in Pivotal Phase 3 TiNivo-2 Study of FOTIVDA(R) in Combination with OPDIVO(R) in Advanced Renal Cell Carcinoma	23-06-27
South Korean Stocks Climb on Demand Recovery Hopes from China; LG Chem Stocks Add 1%	23-01-20
LG Chem Acquires US Biopharma Firm AVEO Pharmaceuticals	23-01-19
AVEO Pharmaceuticals, Inc. Announces Management Changes	23-01-19
AVEO Oncology Appoints Martin Birkhofer as Its Chief Medical Officer	23-01-19
LG Chem, Ltd. completed the acquisition of AVEO Pharmaceuticals, Inc. from a group of shareholders.	23-01-18
AVEO Pharmaceuticals Receives CFIUS Clearance for LG Chem Merger	23-01-18
AVEO Pharmaceuticals Stockholders Approve LG Chem Merger	23-01-06
AVEO Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07
Aveo Pharmaceuticals, Inc. Withdraws Earnings Guidance for the Year 2022	22-11-07
South Korea's Kospi, Kosdaq Decline Ahead of Earnings Season; LG Chem Sheds 3%	22-10-19
LG Chem to Acquire AVEO Pharmaceuticals for $566 Million	22-10-19
MÄRKTE ASIEN/China-Börsen schwach - Parteitag der KP enttäuscht	22-10-19
MÄRKTE ASIEN/China-Börsen hinken wieder hinterher	22-10-19
AVEO Pharmaceuticals to Be Acquired by LG Chem in $566 Million All-Cash Deal; Shares Surge	22-10-18
Sector Update: Health Care Stocks Advance Premarket Tuesday	22-10-18
AVEO Pharmaceuticals Agrees to be Acquired by LG Chem in $566 Million All-Cash Deal; Shares Surge Pre-Bell	22-10-18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages AVEO Pharmaceuticals, Inc.

Equities

AVEO

US0535883070

Other languages

Filters